JP Morgan Chase’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
JP Morgan Chase's EW Position: Q3 2026 in Review
JP Morgan Chase increased its Edwards Lifesciences (EW) stake by 7.4% in Q3 2026, buying an estimated $149M and bringing the position to 24,464,600 shares worth $2.15B. The position accounts for 0.12% of the portfolio, ranked #173.
JP Morgan Chase first reported a position in EW in Q2 2013 and has held it in 54 quarters since. The position peaked at $2.22B in Q4 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- JP Morgan Chase held 24,464,600 shares of Edwards Lifesciences worth $2.15B as of Q3 2026.
- JP Morgan Chase bought 1,681,425 Edwards Lifesciences shares in Q3 2026, an estimated $149M.
- Edwards Lifesciences made up 0.12% of JP Morgan Chase's portfolio in Q3 2026, its #173 holding.
- JP Morgan Chase first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 54 quarters since.
- JP Morgan Chase's Edwards Lifesciences position peaked at $2.22B in Q4 2025.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.